Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would contemplate new talks with insurers concerning the checklist rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Now that some digi… Read More